Content area

Abstract

The current issue was edited because various important developments have taken place since its predecessor was published, especially in medical biomimetic nanotechnology. [...]biomimetics as a field is growing, and has become more consolidated. The contributions come from researchers and thinkers in all realms of biomimetic nanotechnology, and features theoretical, experimental, and review contributions from biologists, biomimeticians, chemists, clinicians, engineers, experts in interface and colloid science, food and nutrition specialists, manufacturing specialists, material scientists, microelectronics experts, nanotechnologists, physicists and systems scientists, who are engaged and interested in this fast-growing field. The specialist fields covered are deep and wide, and comprise original and review articles on biomimetic nanotechnology from dementia research to dentistry (two contributions regard the oral cavity: one focuses on acidic challenges to restorative materials and one on the prevention of detrimental biofilm formation), energy (the generation of hydrogen by water-splitting), nanomembranes (with their vast number of applications), therapies against cancer and multiresistant bacteria, tissue engineering (two contributions: one focuses on the kidney, the other on vascularization) and vaccine design. In their research article “Fabrication of nanoporous polylactic acid microtubes by core-sheath electrospinning for capillary vascularization” [8], the authors report on the development of base ingredients for future complex synthetic tissues, that allow for the creation of vascular networks in engineering constructs.

Full text

Turn on search term navigation

© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.